NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) is an Australian drug development company developing novel peptide-based pharmaceutical products that target a number of neurodegenerative conditions with high unmet medical need.
Therapeutic indications include Alzheimer’s Disease, Multiple Sclerosis, Glaucoma and Post-Covid Lung Fibrosis.
The companies lead compound, EmtinB works by effectively slowing down the death of dying cells and regenerating damaged nerves and tissue fibres.
NeuroScientific Biopharmaceuticals is committed to a research and development program that is methodically planned, efficiently executed and risk aware.
www.neuroscientific.com
Industry
Biotechnology Research, Scientific Research and Development Services, Services
HQ Location
85 Forrest St
Suite 5
Cottesloe, Western Australia 6011, AU
Keywords
Drug developmentTherapeutic peptidesAlzheimer's diseaseGlaucomNeurodegenerative diseaseclinical solutionslead productamyloid plaquespharmaceutical medicineneural cells